Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Epinastine; Olopatadine Hydrochloride

Criteria

Inclusion Criteria:

• Documented history of ocular allergy to cats.

• Positive skin prick allergen reaction to cat dander.

Exclusion Criteria:

• Use of any topical or systemic corticosteroids, immunosuppressive agents, antihistamines, decongestants, NSAIDs, or asprin during the two weeks prior to enrollment into the study.

• History of severe asthma, reactive airway disease or bronchial obstruction.

• Ocular surgery or trauma in the last year.